Business Context and Reporting Period
This Form 8-K Current Report was filed by Oragenics, Inc. on February 2, 2012, covering events occurring on January 27, 2012, and January 28, 2012. The filing addresses significant changes in the Company's executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes
- Departure: Brian Bohunicky resigned as Chief Financial Officer, Secretary, and Treasurer effective January 27, 2012, to pursue other opportunities. The Company expects to provide severance benefits consistent with his employment agreement.
- Appointment: The Board of Directors approved the appointment of Michael Sullivan as the new Chief Financial Officer, Secretary, and Treasurer, effective February 6, 2012.
Guidance, Outlook, and Compensation Details
The filing details the terms of Mr. Sullivan's Executive Employment Agreement:
- Base Salary: Not less than $180,000 annually.
- Bonus: Eligible for bonuses up to 25% of annual salary based on Company and individual targets.
- Severance (Involuntary Termination without Cause): Six months of annual base salary plus outplacement services.
- Change in Control: Stock options vest immediately. If an involuntary separation occurs within 180 days of a change in control, Mr. Sullivan is entitled to six months of salary, a two-month extension of benefits, and a two-month extension to exercise vested options.
- Death or Disability: Salary accrual for 30 days post-event and a six-month extension to exercise vested stock options.
Mr. Sullivan is a Florida Certified Public Accountant with prior experience at Utek Corporation, eANGLER, HSN Direct International Limited, and First Advantage Corporation.
Investor Verification Checklist
- Verify the exact terms of the Executive Employment Agreement attached as Exhibit 10.1.
- Confirm the specific severance package details for the departing CFO, Brian Bohunicky, as the filing only states they will be "consistent with the terms of his employment agreement."
- Review the press release attached as Exhibit 99.1 for additional context on the leadership transition.
- Monitor future filings for the impact of the CFO transition on financial reporting and internal controls.